The genomic landscape of breast cancer is complex, and inter-and intra-tumour heterogeneity
are important challenges in treating the disease. In this study, we sequence 173 genes in …

Background Since a national lockdown was introduced across the UK in March, 2020, in
response to the COVID-19 pandemic, cancer screening has been suspended, routine …

The rates and routes of lethal systemic spread in breast cancer are poorly understood owing
to a lack of molecularly characterized patient cohorts with long-term, detailed follow-up data…

Surgery is essential for global cancer care in all resource settings. Of the 15·2 million new
cases of cancer in 2015, over 80% of cases will need surgery, some several times. By 2030, …

DNA methylation is aberrant in cancer, but the dynamics, regulatory role and clinical implications
of such epigenetic changes are still poorly understood. Here, reduced representation …

The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA
organised a workshop in Milan on 20–21st October 2008 to evaluate the evidence currently …

The burden of cancer is growing, and the disease is becoming a major economic expenditure
for all developed countries. In 2008, the worldwide cost of cancer due to premature death …

Cancer is one of the major non-communicable diseases posing a threat to world health.
Unfortunately, improvements in socioeconomic conditions are usually associated with increased …

Cancer can have profound social and economic consequences for people in India, often
leading to family impoverishment and societal inequity. Reported age-adjusted incidence rates …

Glenn Robert and colleagues describe an approach that aims to ensure that healthcare
organisations realise the full potential of patients—the biggest resource they have for …